ASLO Medtech ApS: Financial statements 2025
CVR: 41009268
Source: annual report 2025, Danish Business Authority
01/05/2024 – 30/04/2025
ASLO Medtech ApS (CVR 41009268) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -113,278 and a net result of DKK -250,478 compared with DKK 2,115 the year before. Equity in the 2025 report amounted to DKK -399,912.
- Gross Profit
- DKK -113,278
- Profit/Loss
- DKK -250,478
- Equity
- DKK -399,912
- Total Assets
- DKK 1,090,490
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -113 t. | -250 t. | -400 t. | 0 |
| 2024 | - | 13 t. | 2 t. | -149 t. | 1 |
| 2023 | - | -22 t. | -87 t. | -152 t. | 1 |
| 2022 | - | -17 t. | -37 t. | -64 t. | 1 |
How creditworthy is ASLO Medtech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout ASLO Medtech ApS
ASLO Medtech ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2019. The company is registered under the industry Speciallægers aktiviteter. The management consists of Sofus Hasselstrøm Tørring. The company is owned by ASLO Medtech Holding ApS. In 2026, the company reported a gross profit of DKK -42,792 and a net result of DKK -309,492 compared with DKK -250,478 the year before. Equity in the 2026 report amounted to DKK -709,404.